Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

Name: Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study
Published: 2003
License: Public Domain

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · 2003

ClinicalTrials.gov · Datasets · License: Public Domain · 2003

Open Source ↗

psychotic-disorders schizophrenia

schizophrenia, psychotic disorders, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

Related documents